Tower Research Capital LLC (Trc) Nexgel, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Nexgel, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,753 shares of NXGL stock, worth $5,819. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,753
Previous 3,533
50.38%
Holding current value
$5,819
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NXGL
# of Institutions
14Shares Held
233KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA56.8KShares$188,7080.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA50KShares$165,9170.0% of portfolio
-
Simon Quick Advisors, LLC35.7KShares$118,5730.01% of portfolio
-
Northeast Financial Group, Inc. Tannersville, PA31.8KShares$105,7350.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny28.5KShares$94,4700.0% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $18.5M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...